> Details

Levitin, Maria O; Rawlins, Lettie E; Sanchez-Andrade, Gabriela; Arshad, Osama A; Collins, Stephan C; Sawiak, Stephen J; Iffland, Phillip H; Andersson, Malin H L; Bupp, Caleb; Cambridge, Emma L; Coomber, Eve L; Ellis, Ian; Herkert, Johanna C; Ironfield, Holly; Jory, Logan; Kretz, Perrine F; Kant, Sarina G; Neaverson, Alexandra; Nibbeling, Esther; Rowley, Christine; Relton, Emily; Sanderson, Mark; Scott, Ethan M; Stewart, Helen; [...]

Models of KPTN-related disorder implicate mTOR signalling in cognitive and overgrowth phenotypes

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Models of KPTN-related disorder implicate mTOR signalling in cognitive and overgrowth phenotypes
  • Contributor: Levitin, Maria O; Rawlins, Lettie E; Sanchez-Andrade, Gabriela; Arshad, Osama A; Collins, Stephan C; Sawiak, Stephen J; Iffland, Phillip H; Andersson, Malin H L; Bupp, Caleb; Cambridge, Emma L; Coomber, Eve L; Ellis, Ian; Herkert, Johanna C; Ironfield, Holly; Jory, Logan; Kretz, Perrine F; Kant, Sarina G; Neaverson, Alexandra; Nibbeling, Esther; Rowley, Christine; Relton, Emily; Sanderson, Mark; Scott, Ethan M; Stewart, Helen; [...]
  • Published: Oxford University Press (OUP), 2023
  • Published in: Brain, 146 (2023) 11, Seite 4766-4783
  • Language: English
  • DOI: 10.1093/brain/awad231
  • ISSN: 0006-8950; 1460-2156
  • Origination:
  • Footnote:
  • Description: Abstract KPTN-related disorder is an autosomal recessive disorder associated with germline variants in KPTN (previously known as kaptin), a component of the mTOR regulatory complex KICSTOR. To gain further insights into the pathogenesis of KPTN-related disorder, we analysed mouse knockout and human stem cell KPTN loss-of-function models. Kptn −/− mice display many of the key KPTN-related disorder phenotypes, including brain overgrowth, behavioural abnormalities, and cognitive deficits. By assessment of affected individuals, we have identified widespread cognitive deficits (n = 6) and postnatal onset of brain overgrowth (n = 19). By analysing head size data from their parents (n = 24), we have identified a previously unrecognized KPTN dosage-sensitivity, resulting in increased head circumference in heterozygous carriers of pathogenic KPTN variants. Molecular and structural analysis of Kptn−/− mice revealed pathological changes, including differences in brain size, shape and cell numbers primarily due to abnormal postnatal brain development. Both the mouse and differentiated induced pluripotent stem cell models of the disorder display transcriptional and biochemical evidence for altered mTOR pathway signalling, supporting the role of KPTN in regulating mTORC1. By treatment in our KPTN mouse model, we found that the increased mTOR signalling downstream of KPTN is rapamycin sensitive, highlighting possible therapeutic avenues with currently available mTOR inhibitors. These findings place KPTN-related disorder in the broader group of mTORC1-related disorders affecting brain structure, cognitive function and network integrity.
  • Access State: Open Access